Showing results (161-170 of 488) with videos related to
Sort By:
Pageof 49
Expert Review of Anticancer Therapy|August 1, 2012
Loss of miR-126 is crucial to pancreatic cancer progressionAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.Journal of Geriatric Oncology|May 6, 2022
Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancerPenny Mackenzie, Claire Vajdic, Geoff Delaney, et al.BMC Complementary and Alternative Medicine|May 11, 2018
Australian integrative oncology services: a mixed-method study exploring the views of cancer survivorsJennifer Hunter, Jane Ussher, Chloe Parton, et al.Technical Innovations & Patient Support in Radiation Oncology|January 1, 2021
Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, AustraliaPenny Mackenzie, Claire Vajdic, Geoff Delaney, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancersPenny Mackenzie, Claire Vajdic, Geoff Delaney, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|July 16, 2016
Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta-AnalysisYuanqing Li, Xiaoshu Zhu, Alan Bensussan, et al.International Journal of Cancer|March 10, 2005
Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort studyLaura Waters, Justin Stebbing, Sundhiya Mandalia, et al.Endocrinology, Diabetes & Metabolism Case Reports|March 27, 2018
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditisPloutarchos Tzoulis, Richard W Corbett, Swarupini Ponnampalam, et al.Clinical Lymphoma & Myeloma|June 16, 2009
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseEleftheria Hatzimichael, George Dranitsaris, Aggeliki Dasoula, et al.Antiviral Research|March 10, 2010
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocDarius Armstrong-James, Justin Stebbing, Andrew Scourfield, et al.Pageof 49